Quotient Clinical and Bend Research have announced a non-exclusive collaboration that can speed the advance of compounds to clinical trials and expand options for drug delivery.
The collaboration combines Bend's advanced drug formulation capabilities and Quotient's clinical trial design service Rapidfact.
The result is a clinical trial programme that will allow clients to screen and select optimised formulations rapidly during human testing.
For example, optimum bioavailability-enhancing formulations relying on amorphous and nanocrystalline dispersions can be quickly identified using Quotient's flexible clinical trial designs.
